SYT: A Potential Drug Target for Neurological Disorders (P46534)

Target Name: Synaptotagmin

NCBI ID: P46534

Other Name(s): SYT

SYT: A Potential Drug Target for Neurological Disorders

Synaptotagmin (SYT) is a protein that is expressed in the rat central nervous system and is involved in the regulation of synaptic strength and neurotransmitter release. It is a member of the neurotrophic factor family and is thought to play a role in the development and maintenance of synaptic plasticity.

Recent studies have suggested that SYT may be a drug target or biomarker for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. This is because SYT has been shown to be involved in the pathophysiology of these conditions and may be a useful target for new treatments.

One of the potential benefits of targeting SYT is its potential to modulate neurotransmitter release and improve synaptic function. This is because SYT is involved in the regulation of neurotransmitter release from dopamine-producing neurons, which are important for various functions in the brain, including mood regulation and movement.

In addition, SYT has also been shown to play a role in the regulation of synaptic strength, which is the ability of synapses to transmit signals. This is important for the development and maintenance of synaptic plasticity, which is the ability of the brain to learn and adapt over time.

SYT has also been shown to be involved in the regulation of axon growth and differentiation, which is important for the development and maintenance of neural circuits. This is important for the development and maintenance of neural circuits, which are responsible for transmitting signals throughout the brain.

In conclusion, SYT is a protein that is involved in the regulation of synaptic strength and neurotransmitter release, and has been shown to play a role in the development and maintenance of synaptic plasticity. As a result, targeting SYT may be a promising approach for the development of new treatments for various neurological and psychiatric disorders.

Protein Name: Synaptotagmin (nonspecified Subtype)

More Common Targets